Medichem is a vertically integrated pharmaceutical company with nearly 50 years of expertise, headquartered in Spain. Specializing in the development and manufacture of APIs and FDFs, the company also offers CDMO services. Positioned as a leader in Chlorhexidine-based products, its portfolio includes approximately 45 APIs and 20 FDFs.
Recognized for its commitment to scientific excellence, quality, and sustainability, Medichem is a certified B Corp serving more than 600 clients across over 60 countries. Their global operations are supported by a team of over 450 professionals in strategic locations including the USA, Malta, and China.
Founded in 1972, Medichem has yet to disclose its most recent funding activity, presenting potential opportunities for investors interested in a well-established player dedicated to sustainable and innovative pharmaceutical manufacturing.